Importation Of Us-authorized Besremi (ropeginterferon Alfa-2b-njft) Injection Due To The Current Shortage Of Canadian-authorized Pegasys (peginterferon Alfa-2a) Injection
Recall Summary Health Canada is allowing the temporary importation of a U.S.-authorized drug called BESREMi to address a shortage of the Canadian-authorized drug PEGASYS in Canada. Both drugs are injectable interferon medications used to treat certain blood cancers. The U.S. version is being made available because of supply issues with the Canadian version, though it has different labeling and packaging.
- Product
- Importation of US-Authorized BESREMi (Ropeginterferon alfa-2b-njft) Injection
- Reason
- Supply - Dosage - Labelling - Packaging
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-03-17
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/1933f256-ee9b-4114-ba84-fcf68cd1c63e